AI assistant
ENTROPY NEURODYNAMICS LIMITED — Director's Dealing 2024
May 5, 2024
64855_rns_2024-05-05_400bd124-496e-4b7f-9431-771d47941fd3.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3X Initial Director’s Interest Notice
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.
| Name of entity | Tryptamine Therapeutics Limited (formerly Exopharm Limited) |
|---|---|
| ABN | 78 163 765 991 |
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Gage Jull |
|---|---|
| Date of appointment | 1 May 2024 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
258,287 – Ordinary Fully Paid Shares
1,418,918 – Ordinary Fully Paid Shares (escrowed for 24 months from the date of official quotation)
10,124,800 – Options @ $0.0531 Exp 5 years from the date of Reinstatement (escrowed for 24 months from the date of official quotation)
- See chapter 19 for defined terms.
Appendix 3X Page 1
11/3/2002
Appendix 3X Initial Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interest.N/A | Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interest.N/A | Number & class of SecuritiesN/A | Number & class of SecuritiesN/A | |
|---|---|---|---|---|
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| – Director’s interests in contractsthe case of a company, interests which come within para | – Director’s interests in contractsthe case of a company, interests which come within para | graph (ii) of the definition of “notifiable interest of a director” should | |
|---|---|---|---|
| sed in this part. | |||
| Detail of contract | l of contract | N/A | |
| Nature of interest | N/A | ||
| Name of registered holder(if issued securities) | N/A | ||
| No. ainter | nd class of securities to whichest relates | N/A |
- See chapter 19 for defined terms.
Appendix 3X Page 2
11/3/2002